FdaApplication
NDA 021817
Identifiers
- fda_app_no: NDA021817
Properties
| Property | Value |
|---|---|
| applicant_name | SANDOZ INC |
| application_type | NDA |
| approval_date | 2007-04-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RECLAST | ZOLEDRONIC ACID | EQ 5MG BASE/100ML | INJECTABLE;INTRAVENOUS |
1 product